EOM Pharmaceutical Holdings Inc. (IMUC)

[lecorb]

IMUC,IN GOOGLE FINANCE:Therapeutics Ltd (NYSEMKT:IMUC) showed a volume of 3.60 million shares by the end of last trade whereas the average volume of the stock remained 5.17 million shares. The stock opened the session at $1.34but then moved to $1.26. At that price, the stock showed a negative performance of -5.97%. ImmunoCellular Therapeutics, Ltd. is a clinical-stage biotechnology company. The Company is engaged in developing immune-based therapies for the treatment of cancers, such as brain, ovarian and other solid tumors.

Will IMUC Get Buyers Even After The Recent Rally? Find Out Here


http://www.sbwire.com/press-releases/traders-buzzers-immunocellular-therapeutics-ltd-nysemktimuc-aeropostale-inc-nysearo-mcewen-mining-inc-nysemuxchelsea-therapeutics-international-ltd-nasdaqchtp-447666.htm